Ads
related to: atgam treatment for aplastic anemia includes two of the best- About MDS and Anemia
Learn How MDS and Anemia Work
And What You Can Do
- MDS Treatment Option
Learn About This Treatment Option
For MDS-Related Anemia
- Get Financial Support
Find Information on Insurance,
Financing and Co-Pay Assistance
- 1L Treatment Results
Read About A Clinical Study On The
Results of A First Line Treatment
- Caregiver Support
Read How You Can Support
A Loved One With MDS-related Anemia
- 2L Treatment Results
Learn About The Results of A
Second Line Treatment Study
- About MDS and Anemia
Search results
Results From The WOW.Com Content Network
Aplastic anemia [2] (AA) [3] is a severe hematologic condition in which the body fails to make blood cells in sufficient numbers. Blood cells are produced in the bone marrow by stem cells that reside there. [4] Aplastic anemia causes a deficiency of all blood cell types: red blood cells, white blood cells, and platelets. [5] [6]
Two antithymocyte globulin (ATG) agents licensed for clinical use in the United States are Thymoglobulin (rabbit ATG, rATG, Genzyme) and Atgam (equine ATG, eATG, Pfizer). Thymoglobulin and Atgam are currently licensed for use in the treatment of renal allograft rejection; Atgam is additionally licensed for use in the treatment of aplastic anemia.
Pure red cell aplasia affects the red blood cells in particular. Pure red cell aplasia (PRCA) or erythroblastopenia refers to a type of aplastic anemia affecting the precursors to red blood cells but usually not to white blood cells. In PRCA, the bone marrow ceases to produce red blood cells. There are multiple etiologies that can cause PRCA.
Aplastic Anemia. Reticulocytopenia is the medical term for an abnormal decrease in circulating red blood cell precursors (reticulocytes) that can lead to anemia due to resulting low red blood cell (erythrocyte) production. [1] Reticulocytopenia may be an isolated finding or it may not be associated with abnormalities in other hematopoietic cell ...
Subsequent investigations have indicated the connection between administration of potassium perchlorate and development of aplastic anemia to be "equivocable at best", which means that the benefit of treatment, if it is the only known treatment, outweighs the risk, and it appeared a contaminant poisoned the 13. [94]
Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. [ 1 ] They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS. [ 1 ][ 2 ] In these situations they decrease the need for blood transfusions. [ 2 ]
Ad
related to: atgam treatment for aplastic anemia includes two of the best